3136 results for «2230»
3136 results
Paravalvular leak closure in TMVR
23 May 2025 – From EuroPCR 2025
This session addresses paravalvular leak closure in transcatheter mitral valve replacement, exploring multiple plug techniques, complex leak management, and combined antegrade and retrograde approaches, providing nuanced insights into challenging mitral prosthesis complications.
Life threatening complications in CTO PCI
23 May 2025 – From EuroPCR 2025
Focus on life-threatening complications during CTO PCI with topics including rotational atherectomy challenges, interventricular septal puncture, surgical retrieval of fractured guidewires, and image-guided strategies for managing multivessel CTO complications, enhancing procedural safety.
Coronary complications: sharing the unusual ones
23 May 2025 – From EuroPCR 2025
This session shares unusual coronary complications including microcatheter tip entrapment, balloon shaft fracture, coronary balloon rupture salvage, and retained equipment retrieval, highlighting innovative solutions and procedural vigilance.
360 management of cardiogenic shock
22 May 2025 – From EuroPCR 2025
This session presents a comprehensive 360-degree approach to managing cardiogenic shock, featuring long-term outcomes of low-profile ventricular assist devices, emergency ECMO implementation in PCI centers without on-site surgery, and pharmacologic strategies comparing cangrelor and ticagrelor efficacy and safety in acute myocardial infarction complicated by cardiogenic shock...
CTO PCI evolution: unlocking new approaches
22 May 2025 – From EuroPCR 2025
Unlock new approaches in chronic total occlusion (CTO) PCI with this session highlighting advanced techniques such as tip-in methods when microcatheters fail, support maximization strategies, rotational direction considerations during CTO, and timing of PCI in ACS patients with non-infarct related CTOs.
TAVI new devices
22 May 2025 – From EuroPCR 2025
Explore the latest innovations in transcatheter aortic valve implantation (TAVI) devices with a focus on coronary protection strategies, cerebral embolic protection integration, management of ventricular migration, and overcoming anatomical challenges such as bicuspid and rheumatic valve disease using novel platforms.
TAVI in bicuspid: all you need to know
22 May 2025 – From EuroPCR 2025
Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.
Best companion's case on coronary complications
22 May 2025 – From EuroPCR 2025
This session showcases expert cases addressing coronary complications during PCI, including novel optimization approaches, managing intervention challenges under pressure, unconventional staged PCI strategies, and decision-making in high-risk scenarios to improve procedural safety and outcomes.
The role of DCB in non-left main true bifurcations
22 May 2025 – From EuroPCR 2025
This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...
Best companions's case on complications in calcified lesions
22 May 2025 – From EuroPCR 2025
Delve into challenging cases involving complications in calcified coronary lesions managed with rotational atherectomy. Topics include unique uses of Rotablation, managing burr entrapment, complex calcium and tortuosity combinations, and addressing perforations resulting from stent optimization and burr retrieval in highly calcified vessels.
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
Peripheral expertise to the rescue
22 May 2025 – From EuroPCR 2025
This session addresses peripheral vascular expertise in managing access complications and occlusions. Learn about approaches to femoral access challenges during TAVI, endovascular solutions for iatrogenic hepatic artery rupture, and unconventional treatments for superficial femoral artery occlusions caused by covered stents.
Procedural planning and risk stratification in multivessel PCI
22 May 2025 – From EuroPCR 2025
This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.
Antiplatelet strategies for patients undergoing PCI
22 May 2025 – From EuroPCR 2025
Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...
Radiation protection: the good and the bad
22 May 2025 – From EuroPCR 2025
This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...
What did we learn from my TAVI complications?
22 May 2025 – From EuroPCR 2025
Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.
Managing ischaemic and bleeding risk of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.
Clinical and technical factors for decision-making in treatment of left main coronary artery disease
22 May 2025 – From EuroPCR 2025
Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.
Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.
Challenges and risks of percutaneous treatment of calcified lesions
22 May 2025 – From EuroPCR 2025
Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.
